Concepedia

Author

Axel Nogai

Charité - Universitätsmedizin Berlin

Also Known As

A Nogai, A. Nogai, Axel Nogai, Nogai, Axel

78

Publications

1.2K

Citations

17

H-Index

31

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinHeidelberg UniversityUniversity Hospital HeidelbergGerman Cancer Research CenterEssen University Hospital
AN

About

Axel Nogai is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

237

2

Cell Biology

3

3

91

3

Health Sciences

1

1

67

4

Allergy

1

1

79

5

Blood Transplantation

1

1

67

Axel Nogai

×

21

Publications

1.1K

Citations

17

H-Index

YearCitations

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Markus M. Heimesaat, Axel Nogai, Stefan Bereswill,

Gut

2010

215

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

Lisa Leypoldt, Diana Tichy, Britta Besemer,

Journal of Clinical Oncology

2023

125

Real-world analysis of teclistamab in 123 RRMM patients from Germany

Christine Riedhammer, Florian Bassermann, Britta Besemer,

Leukemia

2024

87

The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells

Lars Fischer, Olaf Penack, Chiara Gentilini,

Experimental Hematology

2006

81

Cross-Reactivity of Myelin Basic Protein-Specific T Cells with Multiple Microbial Peptides: Experimental Autoimmune Encephalomyelitis Induction in TCR Transgenic Mice

Jane L. Grogan, Achim Kramer, Axel Nogai,

The Journal of Immunology

1999

79

Lipopolysaccharide Injection Induces Relapses of Experimental Autoimmune Encephalomyelitis in Nontransgenic Mice via Bystander Activation of Autoreactive CD4+ Cells

Axel Nogai, Volker Siffrin, Kerstin Bonhagen,

The Journal of Immunology

2005

73

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

Hartmut Goldschmidt, Marc‐Andrea Baertsch, Jana Schlenzka,

Leukemia

2020

67

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region

Rimma Berenstein, Olga Blau, Axel Nogai,

BMC Cancer

2015

44

Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program

Alessandro Rambaldi, Alessandra Iurlo, Alessandro M. Vannucchi,

Blood Cancer Journal

2021

42

Multiple myeloma cells modify VEGF/IL‐6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR‐223

Rimma Berenstein, Axel Nogai, Marlies Waechter,

Molecular Carcinogenesis

2015

40

Page 1